Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 2,880 | 2,206 | 2,315 | 0 | 1,924 |
| Cost of Goods | 1,174 | 1,095 | 1,079 | N/A | 1,045 |
| Gross Profit | 1,706 | 1,111 | 1,236 | N/A | 879 |
| Operating Expenses | 2,428 | -1,000 | 2,151 | 0 | 2,089 |
| Operating Income | -548 | -903 | -836 | N/A | -1,163 |
| Other Income | 3 | 903 | 20 | 0 | 34 |
| Pre-tax Income | -545 | 0 | -816 | 0 | -1,129 |
| Net Income Continuous | -545 | N/A | -816 | N/A | -1,129 |
| Net Income | $-545 | $N/A | $-816 | $N/A | $-1,127 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | N/A | -0.20 |
| EPS Basic Continuous Ops | -0.08 | N/A | -0.12 | N/A | -0.17 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | N/A | -0.20 |
| EPS Diluted Continuous Ops | -0.08 | N/A | -0.12 | N/A | -0.17 |
| EBITDA(a) | $-413 | $2,273 | $-836 | $N/A | $-1,042 |